Chargement en cours...
Enzalutamide: targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer
Significant progress has been made in the understanding of the underlying cancer biology of castration‐resistant prostate cancer (CRPC) with the androgen receptor (AR) signalling pathway remaining implicated throughout the prostate cancer disease continuum. Reactivation of the AR signalling pathway...
Enregistré dans:
| Publié dans: | BJU Int |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744713/ https://ncbi.nlm.nih.gov/pubmed/25818596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.13123 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|